R9U2.F Green Thumb Industries Inc
- Market cap
- EUR 1.24B
- P/E
- 15.8x
- P/B
- 0.75x
- ROE
- 1.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is R9U2.F undervalued?
Graham numberR9U2.F trades 27.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Green Thumb Industries Inc fundamental analysis
No fundamental analysis for Green Thumb Industries Inc yet.
Green Thumb Industries Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Green Thumb Industries Inc
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, i…
Full company profileGreen Thumb Industries Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Green Thumb Industries Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 7.21M | 16.5M | 62.5M | 216M | 557M | 894M | 1.02B | 1.05B | 1.14B | 1.18B | 1.24B |
| Gross Profit | 2.10M | 7.23M | 32.7M | 107M | 304M | 492M | 504M | 526M | 601M | 575M | 571M |
| Operating Income | -2.56M | -4.26M | -23.8M | -27.7M | 106M | 215M | 210M | 185M | 224M | 138M | 114M |
| EBITDA | - | -3.03M | 36.0M | 2.23M | 200M | 330M | 130M | 324M | 392M | 480M | 345M |
| Net Income | -3.10M | -3.74M | -7.86M | -59.1M | 15.0M | 75.4M | 12.0M | 36.3M | 73.1M | 114M | 20.6M |
| EPS | - | -45 | -0.05 | -0.29 | 0.07 | 0.32 | 0.05 | 0.15 | 0.31 | 0.50 | 0.09 |
| Balance Sheet | |||||||||||
| Total Assets | 35.5M | 87.2M | 417M | 1.17B | 1.36B | 2.39B | 2.43B | 2.49B | 2.54B | 2.79B | 2.85B |
| Total Liabilities | 3.62M | 21.8M | 68.1M | 324M | 444M | 766M | 768M | 787M | 748M | 879M | 986M |
| Shareholders' Equity | 31.9M | 62.0M | 345M | 841M | 911M | 1.62B | 1.67B | 1.70B | 1.79B | 1.91B | 1.86B |
| Cash & Short-term Investments | 13.0M | 29.6M | 146M | 46.7M | 83.8M | 230M | 178M | 162M | 172M | 274M | 316M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -3.45M | -4.29M | -17.7M | -18.0M | 95.9M | 132M | 159M | 225M | 195M | 295M | 217M |
| Capital Expenditure | 1.13M | 14.2M | 27.4M | 88.6M | 59.8M | 188M | 180M | 220M | 80.2M | 81.1M | 79.1M |
| Free Cash Flow | - | -18.8M | -34.6M | -107M | 36.1M | -55.8M | -20.9M | 4.93M | 115M | 214M | 138M |
| Ratios | |||||||||||
| ROE | -9.7% | -6.0% | -2.3% | -7.0% | 1.6% | 4.7% | 0.7% | 2.1% | 4.1% | 6.0% | 1.1% |
| ROA | -8.7% | -4.3% | -1.9% | -5.1% | 1.1% | 3.2% | 0.5% | 1.5% | 2.9% | 4.1% | 0.7% |
| Net Profit Margin | -42.9% | -22.6% | -12.6% | -27.3% | 2.7% | 8.4% | 1.2% | 3.4% | 6.4% | 9.7% | 1.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Green Thumb Industries Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 11.0M | 0.05 | 14.6% |
| 2020 | USD 2.79M | 0.01 | 18.6% |
| 2019 | EUR 7.52M | 0.04 | - |
| 2018 | EUR 17.4M | 0.11 | - |
| 2017 | EUR 34.0M | 407 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:368 on Jun 13, 2018.
Who owns Green Thumb Industries Inc
- Insiders 1.71%
- Institutions 8.08%
- Public & others 90.21%
- Shares outstanding 198M
- Free float 192M
Green Thumb Industries Inc company profile
- Company name
- Green Thumb Industries Inc
- Ticker
- R9U2.F
- ISIN
- CA39342L1085
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 4,900
- Fiscal year end
- December
- Address
- 325 West Huron Street, Chicago, IL, United States, 60654
- Phone
- 312 471 6720
- Website
- gtigrows.com
About Green Thumb Industries Inc
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
Green Thumb Industries Inc management
10- Mr. Benjamin KovlerFounder, Chairman & CEO · born 1979
- Mr. Anthony GeorgiadisPresident & Director · born 1978
- Mr. Mathew FaulknerChief Financial Officer · born 1974
- Mr. Bret KravitzGeneral Counsel & Secretary · born 1980
- Mr. Matt NavarroPresident of Operations
- Mr. Josh BarringtonSenior Vice President of Technology
- Ms. Rachel AlbertChief Administrative Officer
- Mr. Andrew Laurence GrossmanEVP of Capital Markets & Investor Relations · born 1974
- Mr. Daniel ShakerSenior Vice President of National Sales · born 1971
- Mr. Matt IngramSenior Vice President of Operations